Earnings History For Harrow Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Earnings history for harrow health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Earnings History For Harrow Health Today - Breaking & Trending Today

Harrow Health (NASDAQ:HROW) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Harrow Health (NASDAQ:HROW – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01), Briefing.com reports. Harrow Health had a negative return on equity of 1.57% and a negative net margin of 19.76%. The firm had revenue […] ....

Earnings History For Harrow Health , Eton Pharmaceuticals Inc , Harrow Health Trading Down , Tower Research Capital , Surface Ophthalmics Inc , Northwestern Mutual Wealth Management Co , Harrow Health Inc , Institutional Investors Weigh In On Harrow Health , Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Harrow Health , Get Free Report , Health Trading Down , Mutual Wealth Management , Research Capital , Forest Capital Management , Captrust Financial Advisors , Lake Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Harrow Health (NASDAQ:HROW) Releases Earnings Results, Misses Estimates By $0.01 EPS

Harrow Health (NASDAQ:HROW) Releases Earnings Results, Misses Estimates By $0.01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , America Corp , Walleye Capital , News Ratings For Harrow Health Daily , Surface Ophthalmics Inc , Harrow Health Inc , Pharmaceuticals Inc , Harrow Health , Eton Pharmaceuticals Inc , Earnings History For Harrow Health , Harrow Health Price Performance , Get Free Report , Street Group , Montreal Can , Lake Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

Harrow Health (HROW) Scheduled to Post Earnings on Thursday

Harrow Health (NASDAQ:HROW – Get Rating) is scheduled to release its earnings data after the market closes on Thursday, May 11th. Analysts expect Harrow Health to post earnings of ($0.05) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Harrow Health Stock Up […] ....

United States , Earnings History For Harrow Health , Harrow Health , Surface Ophthalmics Inc , News Ratings For Harrow Health Daily , Eton Pharmaceuticals Inc , Pharmaceuticals Inc , Cubist Systematic Strategies , American Century Companies Inc , America Corp , Harrow Health Inc , Harrow Health Company Profile , Hedge Funds Weigh In On Harrow Health , Harrow Health Stock , Get Rating , Street Capital , Systematic Strategies , Century Companies , Jane Street Group , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Harrow Health (NASDAQ:HROW) Issues Earnings Results

Harrow Health (NASDAQ:HROW – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.35), MarketWatch Earnings reports. Harrow Health had a negative net margin of 14.11% and a positive return on equity of 13.06%. During the same period last year, […] ....

United States , Goldman Sachs Group Inc , Zacks Investment Research , Harrow Health Company Profile Get Rating , Blackrock Inc , America Corp , Drug Development , Earnings History For Harrow Health , York Mellon Corp , Harrow Health , Harrow Health Inc , Opaleye Management Inc , Get Rating , Marketwatch Earnings , Opaleye Management , Sachs Group , New York Mellon Corp , Health Company Profile , Pharmaceutical Compounding , Pharmaceutical Drug Development , Nasdaq Hrow ,